AI assistant
Sending…
Mawson Infrastructure Group Inc. — Director's Dealing 2017
Nov 28, 2017
35202_dirs_2017-11-27_35e143b8-47ff-4e79-b4df-98119199298d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2017-11-16
Reporting Person: Rimon Gold Assets Ltd (10% Owner)
Reporting Person: Raveh Abir (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| 2016 Convertible Notes | $0.04 | 2017-12-31 | Common Stock, par value $0.001 per share (13906526) | Direct | |
| 2016 Future Investment Rights | $0.06 | 2019-06-30 | Common Stock, par value $0.001 per share (14627926) | Direct | |
| 2017 Convertible Notes | $0.05 | 2017-12-31 | Common Stock, par value $0.001 per share (6071361) | Direct | |
| 2017 Future Investment Rights | $0.06 | 2019-06-30 | Common Stock, par value $0.001 per share (7401034) | Direct |
More from Mawson Infrastructure Group Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 18
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 6
Proxy Solicitation & Information Statement
2026
Feb 4
Regulatory Filings
2026
Feb 2
Major Shareholding Notification
2026
Jan 30